Barton ER - Search Results

1

Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy.

Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G, Sweeney HL, Robbins J, Molkentin JD. Millay DP, et al. Among authors: barton er. Nat Med. 2008 Apr;14(4):442-7. doi: 10.1038/nm1736. Epub 2008 Mar 16. Nat Med. 2008. PMID: 18345011 Free PMC article.

2

Targeting latent TGFβ release in muscular dystrophy.

Ceco E, Bogdanovich S, Gardner B, Miller T, DeJesus A, Earley JU, Hadhazy M, Smith LR, Barton ER, Molkentin JD, McNally EM. Ceco E, et al. Among authors: barton er. Sci Transl Med. 2014 Oct 22;6(259):259ra144. doi: 10.1126/scitranslmed.3010018. Sci Transl Med. 2014. PMID: 25338755 Free PMC article.

3

Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy.

Morine KJ, Bish LT, Selsby JT, Gazzara JA, Pendrak K, Sleeper MM, Barton ER, Lee SJ, Sweeney HL. Morine KJ, et al. Among authors: barton er. Muscle Nerve. 2010 Nov;42(5):722-30. doi: 10.1002/mus.21743. Muscle Nerve. 2010. PMID: 20730876 Free PMC article.

4

The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.

Hammers DW, Hart CC, Matheny MK, Wright LA, Armellini M, Barton ER, Sweeney HL. Hammers DW, et al. Among authors: barton er. Sci Rep. 2020 Aug 21;10(1):14070. doi: 10.1038/s41598-020-70987-y. Sci Rep. 2020. PMID: 32826942 Free PMC article.

5

PTC124 targets genetic disorders caused by nonsense mutations.

Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, Wilde RG, Karp G, Takasugi J, Chen G, Jones S, Ren H, Moon YC, Corson D, Turpoff AA, Campbell JA, Conn MM, Khan A, Almstead NG, Hedrick J, Mollin A, Risher N, Weetall M, Yeh S, Branstrom AA, Colacino JM, Babiak J, Ju WD, Hirawat S, Northcutt VJ, Miller LL, Spatrick P, He F, Kawana M, Feng H, Jacobson A, Peltz SW, Sweeney HL. Welch EM, et al. Among authors: barton er. Nature. 2007 May 3;447(7140):87-91. doi: 10.1038/nature05756. Epub 2007 Apr 22. Nature. 2007. PMID: 17450125

6

Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic mice.

Morine KJ, Bish LT, Pendrak K, Sleeper MM, Barton ER, Sweeney HL. Morine KJ, et al. Among authors: barton er. PLoS One. 2010 Feb 11;5(2):e9176. doi: 10.1371/journal.pone.0009176. PLoS One. 2010. PMID: 20161803 Free PMC article.

7

Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells.

Kobinger GP, Louboutin JP, Barton ER, Sweeney HL, Wilson JM. Kobinger GP, et al. Among authors: barton er. Hum Gene Ther. 2003 Oct 10;14(15):1441-9. doi: 10.1089/104303403769211655. Hum Gene Ther. 2003. PMID: 14577924

8

Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage.

Morine KJ, Sleeper MM, Barton ER, Sweeney HL. Morine KJ, et al. Among authors: barton er. Hum Gene Ther. 2010 Dec;21(12):1735-9. doi: 10.1089/hum.2010.077. Hum Gene Ther. 2010. PMID: 20540606 Free PMC article.

9

Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice.

Barton ER, Wang BJ, Brisson BK, Sweeney HL. Barton ER, et al. Muscle Nerve. 2010 Jul;42(1):22-9. doi: 10.1002/mus.21645. Muscle Nerve. 2010. PMID: 20544921 Free PMC article.

10

Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice.

Bish LT, Yarchoan M, Sleeper MM, Gazzara JA, Morine KJ, Acosta P, Barton ER, Sweeney HL. Bish LT, et al. Among authors: barton er. PLoS One. 2011;6(6):e20856. doi: 10.1371/journal.pone.0020856. Epub 2011 Jun 22. PLoS One. 2011. PMID: 21731628 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page